Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates
Polymers · 01.07.2023 · 15 (13) · 2928
DOI: 10.3390/polym15132928 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Polymers, online erschienen am 01.07.2023. Verfasst von Tarun Virmani und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, MVN University, Haryana 121105, India. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of scientific research King Khalid University, Saudi Arabia, Deanship of Scientific Research, King Khalid University, Saudi Arabia.
Abstract (Originalsprache)
The limitations associated with the conventional treatment of cancer have necessitated the design and development of novel drug delivery systems based mainly on nanotechnology. These novel drug delivery systems include various kinds of nanoparticles, such as polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, hydrogels, and polymeric micelles. Among the various kinds of novel drug delivery systems, chitosan-based nanoparticles have attracted the attention of researchers to treat cancer. Chitosan is a polycationic polymer generated from chitin with various characteristics such as biocompatibility, biodegradability, non-toxicity, and mucoadhesiveness, making it an ideal polymer to fabricate drug delivery systems. However, chitosan is poorly soluble in water and soluble in acidic aqueous solutions. Furthermore, owing to the presence of reactive amino groups, chitosan can be chemically modified to improve its physiochemical properties. Chitosan and its modified derivatives can be employed to fabricate nanoparticles, which are used most frequently in the pharmaceutical sector due to their possession of various characteristics such as nanosize, appropriate pharmacokinetic and pharmacodynamic properties, non-immunogenicity, improved stability, and improved drug loading capacity. Furthermore, it is capable of delivering nucleic acids, chemotherapeutic medicines, and bioactives using modified chitosan. Chitosan and its modified derivative-based nanoparticles can be targeted to specific cancer sites via active and passive mechanisms. Based on chitosan drug delivery systems, many anticancer drugs now have better effectiveness, potency, cytotoxicity, or biocompatibility. The characteristics of chitosan and its chemically tailored derivatives, as well as their use in cancer therapy, will be examined in this review.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, MVN University, Haryana 121105, India.
- Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences, Etawah 206001, India.
- Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, AlFara, Abha 62223, Saudi Arabia.
- Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
ORCID-Profile: Tarun Virmani, Ashwani Sharma, Kamla Pathak, Obaid Afzal
Förderung
- Deanship of scientific research King Khalid University, Saudi Arabia
- Deanship of Scientific Research, King Khalid University, Saudi Arabia
Zitieren
APA
Virmani, T., Kumar, G., Sharma, A., Pathak, K., Akhtar, M. S., Afzal, O., & Altamimi, A. S. A. (2023). Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates. Polymers, 15(13), 2928. https://doi.org/10.3390/polym15132928
Vancouver
Virmani T, Kumar G, Sharma A, Pathak K, Akhtar MS, Afzal O, et al. Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates. Polymers. 2023;15(13):2928. doi:10.3390/polym15132928
BibTeX
@article{Virmani2023,
author = {Virmani, Tarun and Kumar, Girish and Sharma, Ashwani and Pathak, Kamla and Akhtar, Md Sayeed and Afzal, Obaid and Altamimi, Abdulmalik S A},
title = {Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates},
journal = {Polymers},
year = {2023},
volume = {15},
number = {13},
pages = {2928},
doi = {10.3390/polym15132928}
}
EUVIMED